Ozempic Sulfur Burps & Burping: Causes, Foods, OTC Relief Evidence Review

Sulfur burps on Ozempic — the eructations that smell like rotten eggs — are one of the most viral and most underexplained GLP-1 side effects. The mechanism is not a mystery. The Ozempic label^[9] lists eructation as a documented adverse reaction in §6.1. The gastric-emptying delay characterized in the Marathe 2013 GLP-1 review^[1] creates the upstream conditions: food sits longer in the stomach and proximal small bowel, giving sulfate-reducing bacteria (primarily Desulfovibrio species — reviewed in Singh 2023^[5]) more substrate and more dwell-time to convert sulfur-containing amino acids (cysteine, methionine) and inorganic sulfate (from cruciferous vegetables and sulfite preservatives) into hydrogen sulfide gas. The H2S is what your nose registers as rotten egg. This is not a sign of harm or of the medication failing. It is a predictable second-order consequence of the same pharmacology that produces the appetite suppression you want. The interventions are well-characterized: dietary adjustment first; bismuth subsalicylate (Pepto-Bismol) for acute relief — the Suarez 1998 Gastroenterology paper^[4] showed it “markedly decreases hydrogen sulfide release in the human colon”; simethicone for bloating-dominant gas; probiotics with modest evidence. When sulfur burps persist past month two of titration, the differential expands to small intestinal bacterial overgrowth. Sulfur burps with severe upper-abdominal pain radiating to the back are a different conversation — that is a pancreatitis red flag and warrants same-day evaluation.

Sulfur burps on Ozempic — the rotten-egg-smell mystery explained

The viral TikTok complaint is real. Sulfur burps — eructations that smell distinctly of rotten eggs — are a recognized GLP-1 side effect with both an FDA-labeled incidence and a well-characterized gastrointestinal mechanism. The Ozempic prescribing information^[9] lists eructation as a documented adverse reaction in §6.1. In the SUSTAIN-1 monotherapy trial^[3] of once-weekly semaglutide 0.5 and 1.0 mg in type 2 diabetes, eructation was reported at single-digit-percent rates — far below nausea (~15–20%) and diarrhea, but high enough to be a clinically meaningful complaint, particularly during dose titration when gastric emptying is most affected.

Three structural facts about sulfur burps explain why they feel so different from ordinary burping:

(1) The smell is hydrogen sulfide (H2S). Hydrogen sulfide is the same gas that gives rotten eggs and sulfur springs their odor. The human nose detects H2S at parts-per-billion concentrations — you can smell it well below any toxic threshold. It is produced in the gut by a specific microbial class: sulfate-reducing bacteria (SRB), of which the genus Desulfovibrio is the best-characterized. The Singh 2023 review^[5] documents that Desulfovibrio uses inorganic sulfate as a terminal electron acceptor in anaerobic respiration, producing H2S as the metabolic end-product. The Kushkevych 2021 review^[6] characterizes the synergy between H2S and acetate produced by SRB and the gut-inflammation context.

(2) The substrate is sulfur-containing amino acids and inorganic sulfate. SRB consume two main substrate classes. Sulfur-containing amino acids — cysteine, methionine, taurine — are released during digestion of high-protein meals (eggs, red meat, poultry, dairy, whey protein, fish). Inorganic sulfate comes primarily from cruciferous vegetables (broccoli, cabbage, Brussels sprouts, cauliflower, kale), allium vegetables (onions, garlic, leeks), and sulfite preservatives in processed foods (dried fruits, wine). When these substrates sit in the gut for extended periods, SRB convert a meaningful fraction to H2S.

(3) The dwell-time is what changes on Ozempic. Ordinary digestion clears most sulfur substrate before SRB can fully ferment it. GLP-1 receptor agonists slow gastric emptying substantially — the Marathe 2013 review^[1] documented this as one of the canonical GLP-1 pharmacologic effects. Food that would normally leave the stomach in 90–120 minutes can take 3–5 hours or more during titration. The longer dwell-time allows SRB to ferment more sulfur substrate into H2S, which rises up the GI tract and is expelled as a burp.

The pattern is highly reproducible. Most patients who experience sulfur burps can identify the triggering meal within hours: a steak dinner, an egg-heavy breakfast, a broccoli-and-chicken bowl, a whey protein shake. The burps typically begin 2–6 hours after the offending meal and may persist for several hours.

Why delayed gastric emptying causes them

The mechanism chain is direct: GLP-1 receptor activation slows gastric emptying → food sits longer in the stomach and proximal small bowel → sulfate- reducing bacteria have more time and more substrate → more H2S production → more sulfur burps.

The pharmacology. Semaglutide is a GLP-1 receptor agonist with a 7-day half-life. GLP-1 receptors are densely expressed in the pyloric antrum and on the vagal afferents that coordinate gastric motility. Receptor activation reduces antral contractility and increases pyloric tone, which delays the transfer of gastric chyme into the duodenum. The Marathe 2013 review^[1] characterizes this as one of the “cardinal pharmacological effects” of GLP-1 in health and disease. Gastric-emptying half-times measured by scintigraphy can double or triple in the first months of therapy compared with baseline.

The microbiology. The healthy human gut microbiome contains sulfate-reducing bacteria at low to moderate abundance (typically <1% of total reads in 16S rRNA studies). They are obligate anaerobes that thrive in the distal small bowel and colon, where they compete with methanogens and other hydrogen-consuming bacteria for H2 produced by upstream fermentation. SRB use inorganic sulfate (SO4(2-)) or sulfur-containing amino acids as terminal electron acceptors and release H2S as a metabolic byproduct. The Singh 2023 Desulfovibrio review^[5] documents the genus as the dominant SRB in the human gut.

The substrate stoichiometry. A typical high-protein meal (~30 g animal protein) delivers approximately 1–1.5 g of methionine + cysteine, plus smaller amounts of inorganic sulfate and other sulfur compounds. A serving of cruciferous vegetable (1 cup cooked broccoli or cabbage) delivers additional inorganic sulfate via glucosinolate breakdown products. Under ordinary gastric emptying (90–120 minute half-time), the great majority of sulfur substrate is absorbed in the small intestine before reaching the SRB-rich distal compartments. Under GLP-1-slowed emptying (3–5+ hour half-time), substantially more sulfur substrate persists long enough to feed SRB metabolism.

Why some patients get hit harder than others. Three variables drive between-patient variation: baseline SRB abundance in the individual's gut microbiome (highly variable); dietary sulfur load (a high-protein / high-cruciferous diet provides more substrate); and gastric-emptying response to GLP-1 (some patients experience a much larger emptying delay than others, which correlates loosely with nausea severity). Patients who habitually eat a high-meat, high-cruciferous-vegetable diet are systematically more likely to experience sulfur burps than patients on a higher-carbohydrate, lower-protein baseline diet.

The paradox of the high-protein onboarding diet. Most GLP-1 dietary guidance — including ours; see our first-month-on-Ozempic guide — recommends prioritizing protein during titration to preserve lean mass as appetite drops. This is correct nutritional advice. It is also the dietary pattern that maximizes sulfur burp risk, because it loads the GI tract with methionine, cysteine, and taurine right at the moment that gastric emptying is most delayed. The resolution is not to abandon protein-forward eating; it is to spread protein across more meals at smaller volumes, choose lower-sulfur protein sources during the worst weeks, and use the bismuth or simethicone interventions described below.

Foods that make sulfur burps worse (high-protein, cruciferous, sulfur amino acids)

Two food categories drive nearly all sulfur burp incidents: sulfur-amino-acid-rich proteins, and sulfate- or sulfur-compound-rich plant foods.

High-sulfur protein sources (richest in methionine + cysteine + taurine):

• Eggs — particularly the yolk. Eggs are the single most concentrated dietary source of sulfur amino acids per gram of protein. An egg-heavy breakfast (3 eggs, omelet, frittata) is one of the most reliable sulfur-burp triggers patients report.
• Red meat — beef, lamb, pork. High methionine + cysteine content. A 6–8 oz steak is a common trigger meal; smaller portions (3–4 oz) of the same protein are tolerated by many patients without incident.
• Poultry — chicken and turkey. Lower sulfur amino-acid density than red meat per gram, but still meaningful. Chicken breast is a common trigger when consumed in large portions (6+ oz).
• Whey protein — the most concentrated form. A 30 g whey scoop delivers a sulfur-amino-acid load equivalent to a small chicken breast. Many GLP-1 patients who tolerate whole-food protein well report dramatic sulfur burps after a single shake.
• Fish — particularly tuna, mackerel, and aged/canned varieties. Lower trigger profile than eggs or red meat but not zero.
• Dairy — cheese, milk, yogurt. Casein and whey both contribute sulfur amino acids; the lactose component (when present) adds a separate fermentation-gas pathway.

High-sulfur plant foods (rich in inorganic sulfate and sulfur-containing compounds):

• Cruciferous vegetables — broccoli, cabbage, Brussels sprouts, cauliflower, kale, bok choy, watercress, collards. Glucosinolate breakdown products provide a substantial inorganic sulfate load. The classic “cabbage smell” of overcooked crucifers is partly H2S generated during cooking; SRB fermentation in the gut produces more of the same gas downstream.
• Alliums — onions, garlic, leeks, shallots, scallions. Sulfur-containing organic compounds (allyl sulfides, diallyl disulfide) feed SRB metabolism.
• Dried fruits and wine — sulfite preservatives. Sulfites are added as antimicrobials and antioxidants; gut bacteria reduce them to H2S.
• Brassica-family condiments — mustard, horseradish, wasabi. Smaller doses but still contributory.
• Some legumes — particularly when undercooked. Beans contribute oligosaccharides (raffinose family) that ferment to H2 and CO2; if SRB are abundant, some of that H2 is consumed and re-emitted as H2S.

The unlucky combination. A meal that combines a high-sulfur protein with a cruciferous vegetable and is consumed in a large single portion — chicken with broccoli, steak with Brussels sprouts, eggs with sautéed cabbage — is the canonical worst-case sulfur-burp trigger on a GLP-1. The combination loads substrate from both pathways into the slowed GI tract simultaneously.

Foods that do not trigger sulfur burps in most patients: rice, plain pasta, white potato, sweet potato, oats, most fruits, leafy greens (lettuce, spinach, arugula), bell peppers, tomatoes, cucumber, summer squash, zucchini. These foods can be useful “safer” bases for meals during weeks when sulfur burps are prominent. See our first-month-on-Ozempic eating guide for the broader meal-pattern context.

First-line interventions (dietary)

The first interventions for sulfur burps are dietary — they treat the upstream cause rather than the downstream symptom and have no medication-interaction concerns.

(1) Smaller portions, more frequent meals. A 30-g-protein meal twice daily produces more sulfur burps than a 15-g-protein meal four times daily because the per-meal substrate load is what overwhelms the slowed gastric clearance. Spread protein across 4–5 smaller meals rather than 2 large ones. Most patients see measurable improvement within 48–72 hours of portion-restructuring.

(2) Slow eating — chew thoroughly. Aerophagia (air-swallowing) during fast eating contributes to total burp volume independently of H2S production. Even on a fully GLP-1-slowed gut, taking 20–30 minutes to eat a meal and chewing each bite thoroughly reduces eructation frequency. This is mechanically distinct from the H2S mechanism but compounds with it.

(3) De-emphasize the highest-sulfur foods during worst weeks. If sulfur burps cluster around specific meals, the immediate intervention is to reduce the offending foods for 1–2 weeks while titration stabilizes. Egg-heavy breakfasts, large red-meat dinners, and cruciferous-heavy side dishes are the most common targets. Substitute lower-sulfur proteins (chicken thigh, white fish, plant proteins like tofu in smaller portions) and non-cruciferous vegetables (leafy greens, zucchini, bell peppers, summer squash) during the worst window.

(4) Avoid carbonated beverages. CO2 from soda, sparkling water, and beer adds directly to total gastric gas volume, which means more burping overall — and more delivery of any H2S already present to the upper GI tract. This does not reduce H2S production but does reduce the frequency and odor-intensity of eructations.

(5) Time meals away from peak gastric-emptying delay. Many patients report worst symptoms 4–6 hours after eating, often in the late evening or middle of the night. Front-loading the day's larger meals (e.g., a more substantial lunch and a small dinner) can shift the H2S production window into waking hours when burps are simply more manageable.

(6) Hydration. Adequate water intake supports overall GI motility and helps move gastric contents through the pylorus. The hydration intervention is small relative to the dietary changes above but is protective in the broader GLP-1 side-effect picture (it also reduces constipation and helps with nausea).

OTC relief: bismuth subsalicylate vs simethicone vs probiotics

When dietary modification is insufficient, three OTC interventions have different mechanisms and different evidence tiers.

Bismuth subsalicylate (Pepto-Bismol) — strongest evidence for sulfur burps specifically. The Suarez 1998 Gastroenterology paper^[4] established the mechanism: bismuth subsalicylate “markedly decreases hydrogen sulfide release in the human colon.” The bismuth cation binds H2S to form insoluble bismuth sulfide, which is then excreted in stool (and is responsible for the black-stool side effect). This is the most mechanistically targeted OTC intervention for sulfur burps available. Standard adult dosing is 524 mg (two regular-strength chewable tablets or 30 mL liquid) up to every 30–60 minutes, not to exceed 8 doses in 24 hours. Caveats: bismuth subsalicylate is contraindicated in children with viral illness (Reye syndrome risk), should be avoided in the third trimester of pregnancy, and may interact with anticoagulants (the salicylate component has antiplatelet activity). Patients with aspirin allergy should not use it. Black-stool and black-tongue discoloration are expected and benign.

Simethicone (Gas-X, Mylicon, Mylanta Gas) — works on gas bubble surface tension, not on H2S production. Simethicone is a silicon-based antifoaming agent that decreases surface tension of gas bubbles in the GI tract, allowing them to coalesce and be expelled more comfortably. It does not reduce gas production. For bloating-dominant gas symptoms, simethicone is well-tolerated and essentially side-effect free; for sulfur-odor symptoms specifically, it does not address the H2S directly. The Coffin 2011 RCT^[7] tested a combination product (simethicone + activated charcoal + magnesium oxide) in functional dyspepsia and found symptom improvement — the activated charcoal component may also adsorb some H2S. Standard simethicone dosing is 40–125 mg after meals and at bedtime, up to 500 mg/day. Bottom line: useful for bloating that accompanies the sulfur burps; less targeted for the rotten-egg smell itself than bismuth.

Probiotics — modest evidence, slower onset, works on the upstream microbiome. Probiotic interventions aim to compete with sulfate-reducing bacteria for substrate or to alter the upstream carbohydrate-fermentation environment in ways that reduce H2S production. Evidence is suggestive but not definitive. Specific strains studied in GI-gas contexts include Lactobacillus rhamnosus GG, Bifidobacterium species, and Saccharomyces boulardii. The onset is gradual (2–4 weeks of consistent daily use); the magnitude is modest. Probiotics are reasonable as an adjunct to dietary modification and bismuth/simethicone but are not an acute intervention. Choose a clinically-studied multistrain product; avoid the broad-spectrum, ultra-high- CFU formulations marketed for “gut health” without trial data.

Activated charcoal — some adsorption capacity for H2S. Activated charcoal can bind and remove H2S from the GI tract via simple adsorption. Standard dosing is 500–1000 mg after meals. The Coffin 2011 combination-product RCT^[7] is the cleanest available evidence. Important caveat: activated charcoal binds many oral medications nonspecifically. Take charcoal at least 2 hours apart from any oral medications, including birth control, thyroid replacement, and oral GLP-1 (Rybelsus). Ozempic is injected so this is not a concern for the weekly dose, but oral medication interactions still apply.

What does not work: antacids (calcium carbonate, magnesium hydroxide) do not address H2S production and can paradoxically worsen burping by producing CO2 when neutralizing stomach acid. H2 blockers (famotidine) and proton pump inhibitors do not target sulfur burps specifically; reducing gastric acid further can theoretically increase upper-GI bacterial overgrowth and worsen the problem. Mint products may relax the lower esophageal sphincter and increase reflux without addressing the burp mechanism.

When to escalate (SIBO workup, pancreatitis red flag)

Most sulfur burps resolve with dietary modification and OTC support within the first 2–3 months as the gastric-emptying delay stabilizes and the gut microbiome adapts. Two escalation pathways matter:

(1) Sulfur burps persisting past month 3, or worsening rather than improving — consider SIBO evaluation. Small intestinal bacterial overgrowth is a condition in which colonic-type bacteria (including sulfate-reducing species) overpopulate the proximal small bowel. The Yao 2023 review^[8] documents elevated SIBO prevalence in obesity and several obesity-related conditions; the slowed gastric and small- bowel motility from chronic GLP-1 therapy is a plausible SIBO risk factor. Workup is typically a glucose or lactulose breath test measuring hydrogen and methane (and, in some specialized centers, H2S) production after a substrate challenge. SIBO is treated with targeted antibiotics (rifaximin most commonly), dietary modification, and prokinetic support. Discuss with your primary care provider or a gastroenterologist if sulfur burps are accompanied by persistent bloating, distension, weight regain, or new diarrhea/constipation that does not fit your established GLP-1 pattern.

(2) Sulfur burps with severe upper-abdominal pain radiating to the back — same-day evaluation for pancreatitis. Acute pancreatitis is a recognized rare adverse event on GLP-1 therapy. Classic presentation is severe, constant upper-abdominal pain (often described as “boring through to the back”), nausea, and vomiting that does not respond to ordinary antiemetics. Sulfur burps are not a feature of pancreatitis specifically, but patients sometimes report increased burping during the prodromal period. The decision rule is not about the burps; it is about the abdominal pain. Severe new upper-abdominal pain on a GLP-1, particularly with radiation to the back, warrants same-day medical evaluation regardless of the burping pattern. See our full GLP-1 side-effect trial data review for the pancreatitis incidence data and the clinical decision rules.

(3) Sulfur burps with progressive vomiting, inability to keep down liquids, or signs of dehydration — same-day evaluation for gastroparesis or ileus. Severe gastric-emptying delay can progress to functional gastroparesis or, rarely, to ileus or bowel obstruction. These are recognized GLP-1 adverse events under active post-marketing surveillance. The decision rule is the ability to tolerate fluids: a patient who cannot keep water down for >12 hours needs medical evaluation. See our GLP-1 nausea management practical guide for the escalation rules on severe nausea/vomiting.

(4) Sulfur burps with new chest pain, difficulty swallowing, or coffee-ground emesis — emergency evaluation. These are signs of upper-GI bleeding or severe esophagitis, not of the sulfur-burp pathway itself, but patients on GLP-1 with severe persistent eructation occasionally develop reflux-related complications that warrant evaluation.

The natural history for most patients is favorable. Sulfur burps are most prominent during the first 2–3 months of titration, then decrease as the gastric-emptying response stabilizes and the gut microbiome equilibrates to the new transit time. Patients on stable maintenance doses for 6+ months typically experience sulfur burps only after specific trigger meals rather than as a daily symptom. The interventions above bridge the titration window. Use our GLP-1 side-effect timeline tool to compare your symptom progression with the expected trajectory.

FAQ

Common questions, with the honest evidence-based answer for each:

Bottom line

• Sulfur burps on Ozempic are real, FDA-labeled, and have a well-characterized mechanism. The Ozempic label^[9] lists eructation as a documented adverse reaction in §6.1; the SUSTAIN-1 trial^[3] reported single-digit-percent rates in the diabetes population.
• The mechanism is gastric-emptying delay (Marathe 2013 GLP-1 pharmacology review^[1]) feeding sulfate- reducing bacteria — primarily Desulfovibrio, reviewed in Singh 2023^[5] — with more substrate and more dwell-time, producing hydrogen sulfide gas (the rotten- egg smell).
• High-sulfur protein (eggs, red meat, whey, dairy) and high-sulfate plant foods (broccoli, cabbage, Brussels sprouts, onions, garlic, sulfite-preserved foods) are the dominant dietary triggers. The unlucky combination is a high-protein + cruciferous meal in a large single portion.
• First-line intervention is dietary: smaller more frequent meals, slow eating, de-emphasize sulfur-rich foods during worst weeks, avoid carbonated beverages, maintain hydration. Front-load the day's larger meals.
• Strongest-evidence OTC is bismuth subsalicylate (Pepto-Bismol). The Suarez 1998 Gastroenterology paper^[4] showed it “markedly decreases hydrogen sulfide release in the human colon” via bismuth-sulfide precipitation. Standard dosing 524 mg up to every 30–60 minutes, ≤8 doses in 24 hours. Black stools are expected.
• Simethicone helps bloating-dominant gas but does not target H2S production directly; the Coffin 2011 RCT^[7] showed symptom improvement from a simethicone + activated charcoal + magnesium oxide combination in functional dyspepsia. Activated charcoal can adsorb H2S but binds oral medications — dose 2+ hours apart from other oral drugs.
• Probiotics have modest, slow-onset evidence as an upstream-microbiome intervention. The Kushkevych 2021 review^[6] characterizes the H2S-SRB-gut- pathology axis that probiotic interventions aim at. Adjunctive, not acute.
• Persistent sulfur burps past month 3, or symptoms that worsen rather than improve, can warrant small intestinal bacterial overgrowth (SIBO) evaluation — the Yao 2023 review^[8] documents elevated SIBO prevalence in obesity-related conditions. Treated with targeted antibiotics, dietary modification, and prokinetic support.
• Sulfur burps with severe upper-abdominal pain radiating to the back warrant same-day evaluation for pancreatitis — a rare but recognized GLP-1 adverse event. The decision rule is the abdominal pain, not the burping itself.
• For most patients the natural history is favorable: sulfur burps are most prominent during the first 2–3 months of titration and decrease as gastric emptying stabilizes and the microbiome equilibrates.

Related research and tools

• GLP-1 nausea management practical guide — the companion side-effect-management article for the most common GLP-1 GI symptom. Many patients experiencing sulfur burps also experience nausea; the dietary interventions overlap substantially.
• What to eat first month on Ozempic — the broader first-month eating framework. The high-protein-onboarding recommendation in that article is correct nutritional advice that paradoxically maximizes sulfur burp risk; this article explains how to reconcile the two.
• GLP-1 side effects: what the trials actually showed — full STEP-1, SUSTAIN, and PIONEER trial AE incidence tables. Eructation is one row in a much larger AE picture; this article puts the sulfur-burp complaint in context.
• GLP-1 side effect questions answered — the Q&A hub for patient-reported GLP-1 side effects. Cross-reference for the broader symptom landscape (SIBO, gastroparesis, ileus, reflux).
• GLP-1 side-effect timeline tool — interactive tool to compare your symptom progression with the expected trajectory. Sulfur burps peak during weeks 4–12 of titration and typically improve on stable maintenance dosing.
• Semaglutide — the drug-level overview for Ozempic / Wegovy / Rybelsus, including the FDA-labeled adverse-reaction incidence in §6.1.

Important disclaimer. This article is educational and does not constitute medical advice. Sulfur burps with severe upper-abdominal pain radiating to the back warrant same-day medical evaluation for pancreatitis. Persistent vomiting or inability to tolerate fluids on a GLP-1 warrants same-day medical evaluation for severe gastric-emptying delay, gastroparesis, or ileus. Bismuth subsalicylate is contraindicated in children with viral illness, should be avoided in the third trimester of pregnancy, and may interact with anticoagulants. Patients with aspirin allergy should not use bismuth subsalicylate. Activated charcoal binds oral medications nonspecifically — take 2+ hours apart from any oral drug. Discuss persistent sulfur burps past month 3 of titration with your prescriber to evaluate for small intestinal bacterial overgrowth. PMIDs were independently verified against the PubMed E-utilities API on 2026-05-23; FDA-labeled adverse-reaction language is drawn from the Ozempic prescribing information at DailyMed SetID adec4fd2-6858-4c99-91d4-531f5f2a2d79.

Last verified: 2026-05-23. Next review: every 12 months, or sooner if major new evidence on sulfate-reducing bacteria, hydrogen sulfide gut physiology, or GLP-1 gastrointestinal adverse-event profiles is published.